Elisabetta Cerbai

10.9k total citations
195 papers, 5.9k citations indexed

About

Elisabetta Cerbai is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Elisabetta Cerbai has authored 195 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Cardiology and Cardiovascular Medicine, 95 papers in Molecular Biology and 47 papers in Cellular and Molecular Neuroscience. Recurrent topics in Elisabetta Cerbai's work include Cardiac electrophysiology and arrhythmias (105 papers), Ion channel regulation and function (65 papers) and Neuroscience and Neural Engineering (35 papers). Elisabetta Cerbai is often cited by papers focused on Cardiac electrophysiology and arrhythmias (105 papers), Ion channel regulation and function (65 papers) and Neuroscience and Neural Engineering (35 papers). Elisabetta Cerbai collaborates with scholars based in Italy, United States and Germany. Elisabetta Cerbai's co-authors include Alessandro Mugelli, Laura Sartiani, Raffaele Coppini, Francesca Stillitano, Mario Barbieri, Corrado Poggesi, Cecilia Ferrantini, Chiara Tesi, Leonardo Sacconi and Marisa Jaconi and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Elisabetta Cerbai

189 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Cerbai Italy 46 3.7k 3.0k 1.2k 477 434 195 5.9k
Sílvia Guatimosim Brazil 39 3.4k 0.9× 3.7k 1.2× 769 0.6× 480 1.0× 358 0.8× 121 5.8k
Joshua I. Goldhaber United States 42 3.1k 0.9× 3.6k 1.2× 1.1k 0.9× 391 0.8× 466 1.1× 113 5.3k
Itsuo Kodama Japan 43 4.2k 1.1× 2.9k 1.0× 913 0.8× 313 0.7× 471 1.1× 209 5.9k
Tetsushi Furukawa Japan 40 2.8k 0.8× 3.6k 1.2× 922 0.8× 294 0.6× 410 0.9× 154 5.4k
Stephan E. Lehnart Germany 41 5.3k 1.4× 5.8k 1.9× 1.4k 1.2× 545 1.1× 335 0.8× 107 7.9k
Geoffrey W. Abbott United States 38 3.7k 1.0× 5.3k 1.8× 1.9k 1.5× 243 0.5× 737 1.7× 150 6.5k
Robert H. G. Schwinger Germany 44 4.0k 1.1× 3.5k 1.2× 741 0.6× 527 1.1× 728 1.7× 203 6.5k
Björn C. Knollmann United States 46 5.3k 1.5× 4.8k 1.6× 1.1k 0.9× 186 0.4× 426 1.0× 188 7.2k
Andrew Tinker United Kingdom 42 2.0k 0.5× 3.6k 1.2× 1.3k 1.1× 511 1.1× 408 0.9× 190 6.0k
Guy Vassort France 52 4.3k 1.2× 4.8k 1.6× 2.1k 1.7× 658 1.4× 391 0.9× 138 7.2k

Countries citing papers authored by Elisabetta Cerbai

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Cerbai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Cerbai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Cerbai more than expected).

Fields of papers citing papers by Elisabetta Cerbai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Cerbai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Cerbai. The network helps show where Elisabetta Cerbai may publish in the future.

Co-authorship network of co-authors of Elisabetta Cerbai

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Cerbai. A scholar is included among the top collaborators of Elisabetta Cerbai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Cerbai. Elisabetta Cerbai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamargo, Juan, Stefan Agewall, Giuseppe Ambrosio, et al.. (2025). New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024. European Heart Journal - Cardiovascular Pharmacotherapy. 11(3). 292–317. 3 indexed citations
2.
3.
Gigante, Bruna, Juan Tamargo, Stefan Agewall, et al.. (2024). Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(7). 614–645. 3 indexed citations
4.
Spinelli, Valentina, Annunziatina Laurino, Valentina Balducci, et al.. (2024). Interleukin-6 Modulates the Expression and Function of HCN Channels: A Link Between Inflammation and Atrial Electrogenesis. International Journal of Molecular Sciences. 25(22). 12212–12212. 1 indexed citations
5.
Tamargo, Juan, Stefan Agewall, Claudio Borghi, et al.. (2024). New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023. European Heart Journal - Cardiovascular Pharmacotherapy. 10(3). 219–244. 6 indexed citations
6.
Haller, Paul M., Stefan Agewall, Claudio Borghi, et al.. (2024). Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(5). 444–453. 7 indexed citations
7.
Yiangou, Loukia, Chiara Palandri, Elisabetta Cerbai, et al.. (2023). Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome. EP Europace. 25(6). 11 indexed citations
8.
Cerbai, Elisabetta, et al.. (2023). Ethical-legal aspects of organoids and their use in research. Manage risks and legal constraints for the development of ethical research. SHILAP Revista de lepidopterología. 34–44. 1 indexed citations
9.
Santini, Lorenzo, Claudia Duranti, Chiara Palandri, et al.. (2023). Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex. Frontiers in Pharmacology. 14. 1237431–1237431. 4 indexed citations
10.
Berrino, Emanuela, Simone Carradori, Andrea Angeli, et al.. (2021). Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages. Antioxidants. 10(1). 56–56. 24 indexed citations
11.
Scardigli, Marina, Raffaele Coppini, Claudia Crocini, et al.. (2020). Arrhythmia susceptibility in a rat model of acute atrial dilation. Progress in Biophysics and Molecular Biology. 154. 21–29. 4 indexed citations
12.
Aimo, Alberto, Giuseppe Vergaro, Andrea Barison, et al.. (2018). Sex-related differences in chronic heart failure. International Journal of Cardiology. 255. 145–151. 37 indexed citations
13.
Coppini, Raffaele, Luca Mazzoni, Cecilia Ferrantini, et al.. (2017). Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy. Circulation Heart Failure. 10(3). 80 indexed citations
14.
Beltrami, Matteo, Alberto Palazzuoli, Luigi Padeletti, et al.. (2017). The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction. International Journal of Clinical Practice. 72(2). e13050–e13050. 16 indexed citations
15.
Passini, Elisa, Blanca Rodríguez, Ana Mincholé, et al.. (2014). Late sodium current inhibition counteracts pro-arrhythmic mechanisms in human hypertrophic cardiomyopathy. Computing in Cardiology Conference. 41. 861–864. 1 indexed citations
16.
Bosman, Alexis, Laura Sartiani, Valentina Spinelli, et al.. (2013). Molecular and Functional Evidence of HCN4 and Caveolin-3 Interaction During Cardiomyocyte Differentiation from Human Embryonic Stem Cells. Stem Cells and Development. 22(11). 1717–1727. 27 indexed citations
17.
Belus, Alexandra, Nicoletta Piroddi, Cecilia Ferrantini, et al.. (2010). Effects of Chronic Atrial Fibrillation on Active and Passive Force Generation in Human Atrial Myofibrils. Circulation Research. 107(1). 144–152. 46 indexed citations
18.
Chiellini, Grazia, Silvia Suffredini, Sandra Ghelardoni, et al.. (2009). Modulation of cardiac calcium homeostasis by 3-iodothyronamine. European Journal of Heart Failure. 1 indexed citations
19.
Cerbai, Elisabetta, et al.. (2006). Canali If nell'attività di pacemaker del nodo seno-atriale. Giornale italiano di cardiologia. 7(7). 20–28.
20.
Cerbai, Elisabetta, Andrea Crucitti, Roberto Pino, et al.. (1998). In vivo blockade of angiotensin II receptors reduces the development of cell hypertrophy and If amplitude in spontaneously hypertensive rats.. Circulation. 98. 818–818. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvia Guatimosim Breakdown of academic impact, for papers by Joshua I. Goldhaber Breakdown of academic impact, for papers by Itsuo Kodama Breakdown of academic impact, for papers by Tetsushi Furukawa Breakdown of academic impact, for papers by Stephan E. Lehnart Breakdown of academic impact, for papers by Geoffrey W. Abbott Breakdown of academic impact, for papers by Robert H. G. Schwinger Breakdown of academic impact, for papers by Björn C. Knollmann Breakdown of academic impact, for papers by Andrew Tinker Breakdown of academic impact, for papers by Guy Vassort
Rankless by CCL
2026